Northgate Public Services reaches final round for IFC funding with newborn hearing pilot
- NPS reaches final 15 in race for $1M (£800,000) funding for Indian newborn screening pilot
- Run by the International Finance Corporation (IFC), which is part of the World Bank Group, the competition initially attracted 350 participants
- The Indian Health Market is expected to be worth £220 billion by 2020
Mumbai, India: Northgate Public Services (NPS) has reached the final 15 companies competing for US $1 million in funding with a newborn screening pilot in India.
Initially attracting 350 participants, the TechEmerge Health competition is now down to a core group of proposals put forward for funding and project support in the burgeoning Indian health market, expected to be worth £220 billion by 2020. The competition is an innovation of the International Finance Corporation, which is part of the World Bank Group.
NPS' newborn screening proposal builds on the company's leading work in the UK and Ireland, where it has screened hundreds of thousands of newborns for hearing, metabolitic and genetic disorders, among other things.
Being one of the top 15 proposals, Northgate Public Services was invited for submitting yet another proposal in partnership with a major healthcare company in India. The announcement of the winning proposal submitted to the TechEmerge committee is expected shortly.
Speaking about the proposed partnership, Northgate Public Services' Alan Campbell said "The TechEmerge match-making event has indeed been true to its promise of fostering commercial partnerships in Indian healthcare. It has been an amazing platform for innovators in healthcare technology and healthcare providers to network on a collaborative level and build on their synergies to pilot new healthcare technologies in the Indian market. We are excited at the prospects this might bring about and are keen to see what the committee's verdict is."
Northgate Public Services also exhibited their Smart Screening suite of offerings. Easily integrated with clinical hardware and software solutions, these screening solutions (hearing, bloodspot, abdominal aortic aneurism and diabetic retinopathy) enable the early identification and treatment of conditions that may endanger newborns.